Novel colorimetric assay of LSD1 activity using gold nanoparticles.

The Analyst 20120607

[Effect of monoamine oxidase inhibitor on the differentiation of malignant glioma cell].

Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20120601

Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations.

Behavioural brain research 20120421

Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120401

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.

Nature medicine 20120311

The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat.

Pharmacology, biochemistry, and behavior 20120101

Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.

Molecular carcinogenesis 20111201

The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.

Genes, chromosomes & cancer 20111201

Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors.

Human pathology 20111101

Effects of CYP inhibitors on precocene I metabolism and toxicity in rat liver slices.

Chemico-biological interactions 20110905

Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors.

Neuro-oncology 20110801

The effects of the perinatal treatment with 5-hydroxytryptophan or tranylcypromine on the peripheral and central serotonin homeostasis in adult rats.

Neurochemistry international 20110801

Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo.

British journal of pharmacology 20110701

Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors.

Bioorganic & medicinal chemistry 20110615

Thyroid hormone suppression of β-amyloid precursor protein gene expression in the brain involves multiple epigenetic regulatory events.

Molecular and cellular endocrinology 20110606

Serotonergic mechanism underlying tranylcypromine enhancement of nicotine self-administration.

Synapse (New York, N.Y.) 20110601

Simple, direct, and informative method for the assessment of CYP2C19 enzyme inactivation kinetics.

Drug metabolism and disposition: the biological fate of chemicals 20110301

Advances pertaining to the pharmacology and interactions of irreversible nonselective monoamine oxidase inhibitors.

Journal of clinical psychopharmacology 20110201

Identification of human liver cytochrome P450 enzymes involved in the metabolism of SCH 530348 (Vorapaxar), a potent oral thrombin protease-activated receptor 1 antagonist.

Drug metabolism and disposition: the biological fate of chemicals 20110101

The monoamine oxidase (MAO) inhibitor tranylcypromine enhances nicotine self-administration in rats through a mechanism independent of MAO inhibition.

Neuropharmacology 20110101

On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.

Pharmacological research 20101201

Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

The Journal of biological chemistry 20101119

Serotonin syndrome with severe hyperthermia after ingestion of tranylcypromine combined with serotonin reuptake inhibitors and tyramine-rich food in a case of suicide.

Pharmacopsychiatry 20101101

Structural basis of drug binding to CYP46A1, an enzyme that controls cholesterol turnover in the brain.

The Journal of biological chemistry 20101008

[Tranylcypromine for chronic therapy-resistant agoraphobia with panic disorder and recurrent depressive disorder].

Psychiatrische Praxis 20101001

Structurally designed trans-2-phenylcyclopropylamine derivatives potently inhibit histone demethylase LSD1/KDM1 .

Biochemistry 20100803

limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.

Neurotoxicity research 20100801

Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.

Journal of clinical psychopharmacology 20100801

Biochemical, structural, and biological evaluation of tranylcypromine derivatives as inhibitors of histone demethylases LSD1 and LSD2.

Journal of the American Chemical Society 20100519

Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats.

Psychopharmacology 20100301

Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.

Psychiatry research 20100227

Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: role of monoamine oxidase enzyme.

Neurotoxicology 20100101

Gas chromatography-mass spectrometry detection of a norfluoxetine artifact in hydrolyzed urine samples may falsely indicate tranylcypromine ingestion.

Journal of analytical toxicology 20100101

Delirium, thrombocytopenia, insomnia, and mild liver damage associated with MAOI withdrawal.

European journal of clinical pharmacology 20091201

TCP-FA4: a derivative of tranylcypromine showing improved blood-brain permeability.

Biochemical pharmacology 20091201

Ovariectomy increases the formation of prostanoids and modulates their role in acetylcholine-induced relaxation and nitric oxide release in the rat aorta.

Cardiovascular research 20091101

Ti: myths about monoamine oxidase inhibitors perpetuated.

The Australian and New Zealand journal of psychiatry 20091101

Trans-2-phenylcyclopropylamine induces nerve cells apoptosis in zebrafish mediated by depression of LSD1 activity.

Brain research bulletin 20090828

Commentary on STAR*D: a summary and UK perspective.

Journal of psychopharmacology (Oxford, England) 20090801

Tranylcypromine dependence and withdrawal.

The Australian and New Zealand journal of psychiatry 20090601

[Irreversible, non-selective monoamine oxidase inhibitors].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090416

Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.

Journal of medicinal chemistry 20090409

Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells.

European journal of pharmacology 20090214

Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20090128

Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice.

Psychopharmacology 20081201

Antidepressant activity of curcumin: involvement of serotonin and dopamine system.

Psychopharmacology 20081201

Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

Journal of neural transmission (Vienna, Austria : 1996) 20081201

Electroconvulsive therapy and monoamine oxidase inhibitors.

Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20081201

Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.

Pharmacopsychiatry 20081101

Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.

Synapse (New York, N.Y.) 20080801

Complexes of the copper-containing amine oxidase from Arthrobacter globiformis with the inhibitors benzylhydrazine and tranylcypromine.

Acta crystallographica. Section F, Structural biology and crystallization communications 20080701

Chronic ouabain treatment increases the contribution of nitric oxide to endothelium-dependent relaxation.

Journal of physiology and biochemistry 20080601

Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B.

Bioorganic & medicinal chemistry letters 20080515

Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.

Psychopharmacology 20080401

Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Neurochemical research 20080301

Withdrawal from high-dose tranylcypromine.

Clinical toxicology (Philadelphia, Pa.) 20080301

Crystal structure of histone demethylase LSD1 and tranylcypromine at 2.25 A.

Biochemical and biophysical research communications 20080201

Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.

PloS one 20080101

[The treatment of psychotic depression in patients insufficiently responsive to conventional medication and electroconvulsive therapy; what are the options?].

Tijdschrift voor psychiatrie 20080101

The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.

Psychopharmacology 20071101

Not all monoamine oxidase inhibitors are created equal.

Journal of the American Geriatrics Society 20071101

Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice.

Neuropharmacology 20071001

Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat.

Psychopharmacology 20070901

Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders?

Journal of psychiatry & neuroscience : JPN 20070901

Reduced evoked fos expression in activity-related brain regions in animal models of behavioral depression.

Progress in neuro-psychopharmacology & biological psychiatry 20070815

Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.

Biochemistry 20070710

Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.

Synapse (New York, N.Y.) 20070601

Tranylcypromine enhancement of nicotine self-administration.

Neuropharmacology 20070501

Under-recruitment of patients for clinical trials: an illustrative example of a failed study.

Acta psychiatrica Scandinavica 20070501

Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study.

Acta psychiatrica Scandinavica 20070501

trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.

Biochemistry 20070410

STAR*D level IV methodology.

The American journal of psychiatry 20070401

Acute chorea and hyperthermia after concurrent use of modafinil and tranylcypromine.

The American journal of psychiatry 20070401

Motor cortex excitability after vagus nerve stimulation in major depression.

Journal of clinical psychopharmacology 20070401

Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.

Journal of clinical psychopharmacology 20070401

Running exercise- and antidepressant-induced increases in growth and survival-associated signaling molecules are IGF-dependent.

Growth factors (Chur, Switzerland) 20070401

Treatment with low doses of tranylcypromine resulted in a disappointing remission rate.

The American journal of psychiatry 20070301

STAR*D: what have we learned?

The American journal of psychiatry 20070201

Honokiol up-regulates prostacyclin synthease protein expression and inhibits endothelial cell apoptosis.

European journal of pharmacology 20070105

CYP3A4 mediated in vitro metabolism of vinflunine in human liver microsomes.

Acta pharmacologica Sinica 20070101

Hydrazine and amphetamine binding to amine oxidases: old drugs with new prospects.

Journal of neural transmission (Vienna, Austria : 1996) 20070101

Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.

Journal of clinical psychopharmacology 20061001

Keeping our eyes on STAR*D.

The American journal of psychiatry 20060901

Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.

The American journal of psychiatry 20060901

Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice.

The European journal of neuroscience 20060901

Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.

Brain research 20060823

Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.

Journal of clinical pharmacology 20060801

Tranylcypromine: new perspectives on an 'old' drug.

European archives of psychiatry and clinical neuroscience 20060801

Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart.

Life sciences 20060620

Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.

Chemistry & biology 20060601

Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.

CNS spectrums 20060501

Transdermal selegiline: the new generation of monoamine oxidase inhibitors.

CNS spectrums 20060501

Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models.

International journal of pharmaceutics 20060309

Nitric oxide synthesis is required for exercise-induced increases in hippocampal BDNF and phosphatidylinositol 3' kinase expression.

Brain research bulletin 20060115

Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids. I. Synthesis and biological evaluation of lipophilic conjugates of tranylcypromine.

European journal of medicinal chemistry 20051101

[Metabolic kinetics of MN9202 in Beagle dog liver microsomes].

Yao xue xue bao = Acta pharmaceutica Sinica 20051101

The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.

British journal of pharmacology 20051001

Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus.

Psychopharmacology 20050901

The serotonin syndrome.

The New England journal of medicine 20050609

Do antihypertensives make tranylcypromine safer? Three case reports.

The Journal of clinical psychiatry 20050501

Exercise activates the phosphatidylinositol 3-kinase pathway.

Brain research. Molecular brain research 20050427

Receptor rigidity and ligand mobility in trypsin-ligand complexes.

Proteins 20050201

Antidepressant apathy syndrome.

Perspectives in psychiatric care 20050101

Endogenous prostacyclin increases neuronal nitric oxide release in mesenteric artery from spontaneously hypertensive rats.

European journal of pharmacology 20041215

Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxidase.

Journal of medicinal chemistry 20041118

Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.

The Journal of clinical psychiatry 20041101

Medical implications from the crystal structure of a copper-containing amine oxidase complexed with the antidepressant drug tranylcypromine.

FEBS letters 20041022

Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus.

Biochemical pharmacology 20041015

Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.

European journal of pharmacology 20040919

Concomitant use of modafinil and tranylcypromine in a patient with narcolepsy: a case report.

Sleep medicine 20040901

Behavioral alterations in response to fear-provoking stimuli and tranylcypromine induced by perinatal exposure to bisphenol A and nonylphenol in male rats.

Environmental health perspectives 20040801

Monoamine oxidase inhibitors and subarachnoid hemorrhage.

Canadian journal of psychiatry. Revue canadienne de psychiatrie 20040801

Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.

Progress in neuro-psychopharmacology & biological psychiatry 20040701

The biogenic trace amine tyramine induces a pronounced hydroxyl radical production via a monoamine oxidase dependent mechanism: an in vivo microdialysis study in mouse striatum.

Brain research 20040625

Involvement of ceramide in the mechanism of Cr(VI)-induced apoptosis of CHO cells.

Free radical research 20040601

Fluorinated phenylcyclopropylamines. Part 3: Inhibition of monoamine oxidase A and B.

Bioorganic & medicinal chemistry 20040515

Zinc treatment induces cortical brain-derived neurotrophic factor gene expression.

European journal of pharmacology 20040510

Purification and characterization of recombinant human prostacyclin synthase.

Journal of biochemistry 20040401

Fluorinated phenylcyclopropylamines. 1. Synthesis and effect of fluorine substitution at the cyclopropane ring on inhibition of microbial tyramine oxidase.

Journal of medicinal chemistry 20040325

Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain.

Pharmacology, biochemistry, and behavior 20040201

Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.

Cellular and molecular neurobiology 20040201

[Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].

Nederlands tijdschrift voor geneeskunde 20031004

[Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].

Nederlands tijdschrift voor geneeskunde 20031004

Successful suppression of cataplectic attacks with tramadol.

Neurology 20030923

Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors.

Pharmacology, biochemistry, and behavior 20030901

Fatal interaction between tranylcypromine and imipramine.

European psychiatry : the journal of the Association of European Psychiatrists 20030801

Scaling down.

The American journal of psychiatry 20030501

Inhibition of six copper-containing amine oxidases by the antidepressant drug tranylcypromine.

Biochimica et biophysica acta 20030411

Noradrenergic and serotonergic blockade inhibits BDNF mRNA activation following exercise and antidepressant.

Pharmacology, biochemistry, and behavior 20030401

[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.

Synapse (New York, N.Y.) 20030201

Effects of stress and tranylcypromine on amphetamine-induced locomotor activity and GABA(B) receptor function in rat brain.

Life sciences 20030117

Does depression influence symptom severity in irritable bowel syndrome? Case study of a patient with irritable bowel syndrome and bipolar disorder.

Psychosomatic medicine 20030101

Antidepressant drug treatment induces Arc gene expression in the rat brain.

Neuroscience 20030101

Effects of tranylcypromine on the sleep of patients with anergic bipolar depression.

Psychopharmacology bulletin 20030101

Endogenous nitric oxide reduces microvascular permeability and tissue oedema during exercise in cat skeletal muscle.

Journal of vascular research 20030101

Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits.

Neuropharmacology 20021101

Probing the catalytic mechanism of Escherichia coli amine oxidase using mutational variants and a reversible inhibitor as a substrate analogue.

The Biochemical journal 20020801

Successful treatment of a complicated case of neuroleptic malignant syndrome.

Intensive care medicine 20020701

The N-demethylation of the doxepin isomers is mainly catalyzed by the polymorphic CYP2C19.

Pharmaceutical research 20020701

Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice.

Journal of psychiatry & neuroscience : JPN 20020501

Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO).

Journal of neural transmission (Vienna, Austria : 1996) 20020301

Endothelin-1 reduces microvascular fluid permeability through secondary release of prostacyclin in cat Skeletal muscle.

Microvascular research 20020101

Modulation of prostacyclin and thromboxane secretion by cytotrophoblasts from normal and pre-eclamptic human pregnancies.

Placenta 20020101

[Protease inhibitors as an anesthetic component in ENT surgery].

Anesteziologiia i reanimatologiia 20020101

[Use of transamine during general anesthesia in facial dermabrasion].

Anesteziologiia i reanimatologiia 20020101

Region-dependent effects of acute and chronic tranylcypromine in vivo on [3H]2-BFI binding to brain imidazoline I(2) sites.

European journal of pharmacology 20011005

Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test.

Life sciences 20010907

Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.

Drug metabolism and disposition: the biological fate of chemicals 20010601

Synthesis and antidepressant activities of some 3,5-diphenyl-2-pyrazolines.

European journal of medicinal chemistry 20010601

Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries.

Journal of cardiovascular pharmacology 20010501

Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model.

Behavioural brain research 20010408

In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.

Drug metabolism and disposition: the biological fate of chemicals 20010301

Ping-pong gaze in combined intoxication with tranylcypromine, thioridazine, and clomipramine.

Neuropsychiatry, neuropsychology, and behavioral neurology 20010101

Stroke resulting from a rapid switch from phenelzine to tranylcypromine.

The Journal of clinical psychiatry 19980701

Experience with tranylcypromine in early Parkinson's disease.

Journal of neural transmission. Supplementum 19980101

[Mianserin-induced hypertension 2 weeks after discontinuation of tranylcypromine].

Der Nervenarzt 19970701

Serotonin syndrome from venlafaxine-tranylcypromine interaction.

Veterinary and human toxicology 19961001

Successful treatment of serotonin syndrome with chlorpromazine.

The Medical journal of Australia 19960916

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

The Journal of neuroscience : the official journal of the Society for Neuroscience 19960401

Venlafaxine.

Nursing 19960301

Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19950501

Fluoxetine and the serotonin syndrome.

Annals of emergency medicine 19941101

[A case of tranylcypromine-induced hallucination].

Psychiatrische Praxis 19930501

[Intracranial hemorrhage following use of MAO inhibitor tranylcypromine and beer].

Nederlands tijdschrift voor geneeskunde 19930501

Tranylcypromine withdrawal phenomena.

Journal of psychiatry & neuroscience : JPN 19930101

Capgras syndrome in association with lithium toxicity.

The British journal of psychiatry : the journal of mental science 19911201

Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome.

Journal of clinical psychopharmacology 19910801

Interaction of butorphanol, with monoamine oxidase inhibitor, tranylcypromine.

Forensic science international 19910301

Symptoms of major depression: acute effect of withdrawing antidepressants.

Acta psychiatrica Scandinavica 19910301

[The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].

Farmakologiia i toksikologiia 19910101

Monosodium glutamate and tranylcypromine administration in healthy subjects.

The Journal of clinical psychiatry 19900701

Adverse consequences of fluoxetine-MAOI combination therapy.

The Journal of clinical psychiatry 19900601

Afternoon fatigue and somnolence associated with tranylcypromine treatment.

The Journal of clinical psychiatry 19900501

Hypertensive crisis precipitated by a monoamine oxidase inhibitor in a patient with phaeochromocytoma.

BMJ (Clinical research ed.) 19900303

Hypertensive episodes with tranylcypromine treatment.

Journal of clinical psychopharmacology 19890601

Hypertensive crisis and broad complex bradycardia after a single dose of monoamine oxidase inhibitor.

BMJ (Clinical research ed.) 19890408

Autoinduction of hypertensive reactions by tranylcypromine?

Journal of clinical psychopharmacology 19890201

Common side effects associated with monoamine oxidase inhibitors.

Progress in neuro-psychopharmacology & biological psychiatry 19890101

Severe daytime somnolence in patients treated with an MAOI.

The American journal of psychiatry 19881201

Cardiac myonecrosis and monoamine oxidase inhibitor therapy.

The American journal of medicine 19871001

Fatal disseminated intravascular coagulation following a monoamine oxidase inhibitor/tricyclic interaction.

Anaesthesia 19870701

Treatment of MAOI hypertensive crisis with sublingual nifedipine.

The Journal of clinical psychiatry 19870601

Hypertension during anaesthesia with monoamine oxidase inhibitors.

Anaesthesia 19870601

Cardiac myonecrosis in hypertensive crisis associated with monoamine oxidase inhibitor therapy.

The American journal of medicine 19870501

Yohimbine- and tranylcypromine-induced postural hypotension.

The American journal of psychiatry 19870101

Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.

The American journal of psychiatry 19851201

Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.

The New England journal of medicine 19850704

Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.

The American journal of psychiatry 19850401

Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.

Journal of clinical psychopharmacology 19850201

Brain monoamine oxidase in suckling rabbits treated with organophosphorus compound. I. Acute intoxication.

Acta physiologica Polonica 19840101

The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. A controlled trial.

Archives of general psychiatry 19830601

Does prostacyclin mediate alpha-adrenergic induced hypotension?

Documenta ophthalmologica. Advances in ophthalmology 19820930

Reversal by bethanechol of sexual dysfunction caused by anticholinergic antidepressants.

The American journal of psychiatry 19820901

Hypertensive crisis resulting from avocados and a MAO inhibitor.

Drug intelligence & clinical pharmacy 19811101

Atrial flutter/fibrillation associated with tranylcypromine treatment.

Journal of clinical psychopharmacology 19811101

Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.

British journal of clinical pharmacology 19810501

Alteration of lidocaine- or procaine-induced convulsions by manipulation of brain amines.

Journal of dental research 19810201

Reduction of ECS-induced retrograde amnesia of passive avoidance conditioning after 5,7-dihydroxytryptamine median raphe nucleus lesion in the rat.

Neuropsychobiology 19810101

Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis.

Prostaglandins and medicine 19791001

Degraded protein-containing food and monoamine oxidase inhibitors.

The American journal of psychiatry 19771201

Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.

British journal of pharmacology 19770201

The tranylcypromine isomers: a controlled clinical trial.

The American journal of psychiatry 19740901

Letter: Side effect of tranylcypromine.

British medical journal 19740831

Severe hyperpyrexia due to tranylcypromine-amphetamine toxicity.

Annals of internal medicine 19690301

Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.

Proceedings of the Western Pharmacology Society 19660101